XML 70 R57.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Restatement of Consolidated Statement of Cash Flow (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities:    
Net loss $ (30,736,098) $ (110,712,948)
Net loss   (110,712,948)
Adjustments to reconcile net loss to net cash (used in) operating activities:    
Depreciation and amortization 242,436 244,208
Unrealized foreign exchange (gain)/loss 375,298 (277,838)
Share based compensation issued to related parties for consultancy services 3,646,017 39,501,701
Share based compensation for consultancy services   18,417,816
Employee share based compensation 5,079,201 2,115,015
Impairment of ROU asset, net of lease termination   46,236
Impairment of prepayments and other current assets   731,940
Impairment of accounts receivable   334,952
Impairment of goodwill   44,438
Impairment of investment in ANY   14,600,000
Interest expense 4,791,782 3,884,695
Changes in operating assets and liabilities:    
Decrease/(increase) in accounts receivable (3,679) 712,554
(Increase) in prepayment and other current assets (416,069) (56,523)
(Decrease) in operating lease liability   (46,236)
Decrease in receivable with related parties   168,754
Increase in accounts payable, accrued expenses and other payables 2,310,465 3,340,539
Increase (decrease) in payables to related parties 552,456 161,791
Net cash used in operating activities (13,001,875) (26,788,906)
Cash Flows from Investing Activities:    
Purchase of property and equipment (14,376) (36,854)
Development of intangible assets (1,767,148)  
Net cash provided by investing activities (1,781,524) (36,854)
Cash Flows from Financing Activities:    
Proceeds from issuance of ordinary shares   2,499,920
Proceeds from long-term debt obligation 2,625,000 21,500,000
Net cash provided by (used in) financing activities 14,712,061 23,999,920
Effect of exchange rate changes on cash 42,399 177,287
Net change in cash (28,939) (2,648,553)
Cash, beginning of the period 39,380 2,687,933
Cash, end of the period 10,441 39,380
As filed [Member]    
Cash Flows from Operating Activities:    
Net loss   (104,105,437)
Net loss   (104,105,438)
Adjustments to reconcile net loss to net cash (used in) operating activities:    
Depreciation and amortization   742,113
Unrealized foreign exchange (gain)/loss   (277,838)
Share based compensation issued to related parties for consultancy services   39,501,701
Share based compensation for consultancy services   18,417,816
Employee share based compensation   2,115,015
Impairment of ROU asset, net of lease termination   46,236
Impairment of prepayments and other current assets   731,940
Impairment of accounts receivable   334,952
Impairment of goodwill   7,418,302
Deferred tax benefit   (243,835)
Interest expense   3,884,695
Changes in operating assets and liabilities:    
Decrease/(increase) in accounts receivable   646,661
(Increase) in prepayment and other current assets   (215,468)
(Decrease) in operating lease liability   (46,236)
Decrease in receivable with related parties   (245,266)
Increase in accounts payable, accrued expenses and other payables   4,766,607
Increase (decrease) in payables to related parties   (234,880)
Net cash used in operating activities   (26,762,923)
Cash Flows from Investing Activities:    
Purchase of property and equipment   (25,973)
Net cash provided by investing activities   (25,973)
Cash Flows from Financing Activities:    
Proceeds from issuance of ordinary shares   2,499,920
Proceeds from long-term debt obligation   21,500,000
Net cash provided by (used in) financing activities   23,999,920
Effect of exchange rate changes on cash   140,658
Net change in cash   (2,648,318)
Cash, beginning of the period 41,709 2,690,024
Cash, end of the period   41,709
Restatement adjustments [Member]    
Cash Flows from Operating Activities:    
Net loss 6,600,000 (31,585,141)
Net loss   (6,607,510)
Adjustments to reconcile net loss to net cash (used in) operating activities:    
Depreciation and amortization   (497,905)
Impairment of goodwill   (7,373,864)
Impairment of investment in ANY   14,600,000
Deferred tax benefit   243,835
Changes in operating assets and liabilities:    
Decrease/(increase) in accounts receivable   65,893
(Increase) in prepayment and other current assets   158,945
Decrease in receivable with related parties   414,020
Increase in accounts payable, accrued expenses and other payables   (1,426,068)
Increase (decrease) in payables to related parties   396,671
Net cash used in operating activities   (25,983)
Cash Flows from Investing Activities:    
Purchase of property and equipment   (14,376)
Development of intangible assets   (1,767,148)
Net cash provided by investing activities   (1,781,524)
Cash Flows from Financing Activities:    
Effect of exchange rate changes on cash   36,639
Net change in cash   (235)
Cash, beginning of the period $ (2,329) (2,091)
Cash, end of the period   $ (2,329)